by Ludivine Félix | Sep 29, 2021 | Blog article
The life sciences and health technologies (LSHT) sector’s response to COVID-19 has been extraordinary. Early into thepandemic, we witnessed organizations around the world—some direct competitors—teaming up to accelerate research into vaccines and treatments. Today,...
by Ludivine Félix | Sep 28, 2021 | Press release
The company and its partners have secured CAD$1 million to apply and improve MFI’s virtual drug-design software in support of preclinical research targeting antibiotic-resistant bacteria and non-alcoholic fatty liver disease. MONTREAL, QUEBEC, September 28, 2021 –...
by Ludivine Félix | Sep 28, 2021 | Communiqué de presse
La société et ses partenaires ont obtenu un million de dollars canadiens pour appliquer et améliorer le logiciel de conception virtuelle de médicaments de MFI à l’appui de la recherche préclinique ciblant les bactéries résistantes aux antibiotiques et la maladie...
by Ludivine Félix | Sep 10, 2021 | Blog article
“Being an entrepreneur means constantly adapting. Adapting to consumers, to new ways of doing things, but also being ahead of the curve, identifying tomorrow’s trends and taking actions before others,” Joseph Mantagaris, founder and CEO of 21st...
by Ludivine Félix | Sep 1, 2021 | Blog article
With almost 20% annual growth, a unique business model and four operating sites, Paraza Pharma is planning to continue its expansion. Quebec is a world leader in the pharmaceutical industry. A number of Quebec’s leading companies in the sector, such as Paraza...
